Zhongguancun announced that the twelfth batch of drugs organized by the national organization was selected for centralized procurement of tramadol hydrochloride injections from Duoduo Pharmaceutical, a subsidiary of the company. The product is used to treat moderate to severe pain. The specification is 2ml: 100mg. The product's sales revenue in 2025 was approximately RMB 30,36,600, accounting for 1.62% of the company's biomedical business revenue. Duoduo Pharmaceutical was one of the 5 selected companies. After the execution of this collection, it is beneficial to increase product sales and market share.
Zhitongcaijing · 1d ago
Share
Listen to the news
Zhongguancun announced that the twelfth batch of drugs organized by the national organization was selected for centralized procurement of tramadol hydrochloride injections from Duoduo Pharmaceutical, a subsidiary of the company. The product is used to treat moderate to severe pain. The specification is 2ml: 100mg. The product's sales revenue in 2025 was approximately RMB 30,36,600, accounting for 1.62% of the company's biomedical business revenue. Duoduo Pharmaceutical was one of the 5 selected companies. After the execution of this collection, it is beneficial to increase product sales and market share.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending